WHY CHOOSE KESIMPTA
RMS TREATMENT ON YOUR TERMS
KESIMPTA® is the only B-cell treatment you can take just once a month* from the comfort of home—or bring with you.
What KESIMPTA Offers
Check out the powerful results† of KESIMPTA
Review the proven safety profile†
Learn about the easy-to-use‡ auto-injector pen
†Proven to reduce relapses and disability progression in 2 studies vs teriflunomide.
‡As seen in a real-world 30-question survey of 105 US patients (aged ≥18) diagnosed with RMS for 1+ years who took KESIMPTA with the auto-injector pen within previous 12 months. On a scale of 1-5, 89.5% of patients rated it a 4 or 5 (5 being most positive) on overall ease of use and ease of monthly dosing schedule. Questionnaire not validated.
WALT D.
Dad, Engineer, and Real Patient
Chose KESIMPTA as 1st treatment: 2021
“I have a busy work schedule and an active lifestyle, so being able to take my KESIMPTA treatment at home, on my time, was the right choice for me. My son loves being outdoors and I want to be able to keep up with that, now and in the future.“
Up Next:
Explore the powerful† results of KESIMPTA.
Want more info to help you decide?
Find out why so many people are choosing KESIMPTA.
Want co-pay help?
96% of all prescriptions filled paid as little as $0 out of pocket cost when used with the Co-Pay Plus offer.§ ||
MS, multiple sclerosis; RMS, relapsing multiple sclerosis.
§Limitations apply. Valid only for those with private insurance. The Program includes the Co-Pay Plus offer, Plus Card (if applicable), and Rebate, with a combined annual limit up to $18,000. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice. See complete Terms & Conditions at start.kesimpta.com.
||2025 data on file.